Abstract
Background: Since May 2022, that has been largest-ever spread of monkeypox in countries where it is not normally found. Since India is home to about 36% of the world’s population, an MPXV outbreak there might have far-reaching consequences. A fuller understanding of the monkeypox virus and the epidemiology of the disease is urgently needed to help clinicians, public health professionals, and politicians be prepared for any eventuality, especially given the speed with which it has spread to non-endemic nations. Aim: Review provides an overview of the epidemiology, clinical characteristics, treatments, vaccinations, and herbal resources used in the management of infection for the monkeypox disease. Immune-compromised host & group require to be given additional notice as the illness is known to have significant effects on pregnant women; we have also highlighted relevant information about such pathophysiological situations in this work. Result and conclusion: The spread of monkeypox virus (2022) in non-endemic nations could provide India with an opportunity to investigate the Krimighna medications mentioned in Brihatrayee, i.e.Charak Samhita, Sushruta Samhita and Ashtanga Hridaya with antiviral activity and to develop novel and useful antiviral agents to combat the monkeypox menace effectively.
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call